Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice
Craig W. Freyer(Hospital of the University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Tracy M. Krause(Hospital of the University of Pennsylvania), James K. Mangan(UC San Diego Health System), Alexander E. Perl(University of Pennsylvania), Alison W. Loren(University of Pennsylvania), David L. Porter(Chapman University), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Mitchell E. Hughes(Hospital of the University of Pennsylvania), Colleen Timlin(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Alex Ganetsky(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Mary Ellen Martin(University of Pennsylvania)
Cited by 3
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907